Safety and effectiveness of dupilumab in the treatment of atopic dermatitis in Japanese patients: the first interim analysis report from postmarketing surveillance

被引：0
|
作者：
Fujita, H. [1 ]
Suzuki, K. [1 ]
Arima, K. [1 ]
机构：
[1] Sanofi KK, Tokyo, Japan
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2022年 / 186卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
605
引用
收藏
页码：E142 / E142
页数：1
相关论文
共 50 条
  • [41] Real-life effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis
    Salman, Andac
    Sengun, Ozlem Apti
    Aktas, Meryem
    Taskapan, Oktay
    DERMATOLOGIC THERAPY, 2022, 35 (01)
  • [42] EVALUATION OF THE EFFECTIVENESS AND SAFETY OF THE TREATMENT WITH DUPILUMAB IN ADULT PATIENTS WITH SEVERE ATOPIC DERMATITIS IN THE B.124 PROGRAM - THE FIRST REAL WORLD EVIDENCE FROM ONE POLISH CENTRE
    Ceryn, Justyna
    Kierstan, Monika
    Narbutt, Joanna
    Lesiak, Aleksandra
    ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 52 - 53
  • [43] Treatment of atopic dermatitis with dupilumab A retrospective cohort analysis from dermatological practice
    Jahn, Sigbert
    Foehr, Julia
    Diamanti, Evangelia
    Herbst, Matthias
    HAUTARZT, 2021, 72 (12): : 1071 - 1078
  • [44] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Fujii, Koichi
    Yoshinaga, Takunari
    Freundlich, Bruce
    Suzukawa, Michio
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1617 - 1624
  • [45] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Takao Koike
    Masayoshi Harigai
    Shigeko Inokuma
    Naoki Ishiguro
    Junnosuke Ryu
    Tsutomu Takeuchi
    Yoshiya Tanaka
    Hisashi Yamanaka
    Koichi Fujii
    Takunari Yoshinaga
    Bruce Freundlich
    Michio Suzukawa
    Rheumatology International, 2012, 32 : 1617 - 1624
  • [46] Safety and efficacy of regorafenib in Japanese patients with metastatic colorectal cancer (mCRC) in clinical practice: Interim result from postmarketing surveillance (PMS).
    Komatsu, Yoshito
    Muro, Kei
    Yamaguchi, Kensei
    Uetake, Hiroyuki
    Satoh, Taroh
    Yoshino, Takayuki
    Nishida, Toshirou
    Yamazaki, Naoya
    Takigawa, Hajime
    Hamada, Yoko
    Chosa, Masayuki
    Sunaya, Toshiyuki
    Yamamoto, Yuka
    Ito, Yuichiro
    Watanabe, Toshiaki
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [47] Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study
    Kaku, Kohei
    Chin, Rina
    Naito, Yusuke
    Iliev, Hristo
    Ikeda, Rie
    Ochiai, Kaori
    Yasui, Atsutaka
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (02) : 211 - 221
  • [48] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Simpson, Eric L.
    Lockshin, Ben
    Lee, Lara Wine
    Chen, Zhen
    Daoud, Moataz
    Korotzer, Andrew
    DERMATOLOGY AND THERAPY, 2024, 14 (01) : 261 - 270
  • [49] Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry
    Eric L. Simpson
    Ben Lockshin
    Lara Wine Lee
    Zhen Chen
    Moataz Daoud
    Andrew Korotzer
    Dermatology and Therapy, 2024, 14 : 261 - 270
  • [50] Safety and effectiveness of etanercept for treatment of juvenile idiopathic arthritis: Results from a postmarketing surveillance
    Mori, Masaaki
    Sugiyama, Naonobu
    Morishima, Yosuke
    Sugiyama, Noriko
    Kokubo, Takeshi
    Takei, Syuji
    Yokota, Shumpei
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 101 - 107
12345